BRNS vs CHD · rev $15.0M vs P/E 32, rev $6.11B
Barinthus Biotherapeutics plc (BRNS) versus Church & Dwight Company Inc (CHD) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Latest reported BRNS revenue for 2024-12-31 was $15.0M. Net income was -$61.2M. Revenue was up 1766.5% from 2023-12-31 to 2024-12-31. BRNS currently screens at market cap $38.2M.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
BRNS currently screens at market cap $38.2M. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Not investment advice. Open the BRNS and CHD stock pages for the full models.
Not investment advice.